Irritable Bowel Syndrome (IBS)
Functional gut disorder with pain and altered bowels — where gut-lining and anti-inflammatory peptides are discussed.
IBS is a functional disorder without structural damage, which makes any compound's role speculative. Interest centres on BPC-157 (gut protection) and KPV (anti-inflammatory), aimed at the low-grade inflammation and barrier issues some IBS subtypes show.
Evidence in IBS specifically is essentially absent. The proven approaches are dietary (e.g. low-FODMAP), gut-brain therapies, and targeted symptom management with a clinician.
Compounds researched
Ranked by editorial relevance — a measure of how central each compound is to the conversation, not a claim of effectiveness.